Holger Memmesheimer, PhD Boehringer Ingelheim

Dr. Holger Memmesheimer studied Chemistry at the University of Kaiserslautern. Following the completion of his PhD in Organic Chemistry and some post-doctoral studies in the UK, he started his industrial career at Shell (later American Cyanamid) in Environmental Chemistry and Chemical Process Development.

In 2000, he joined Boehringer Ingelheim as Head of an Analytical Laboratory in R&D. In 2003, he was appointed as a Director, with responsibility for Drug Product Analytics and Formulation Development and Metered Dose Inhaler Projects. In 2010, he took responsibility for all analytical functions in respect to the development of inhalative dosage forms. From 2013 to 2014, he was in charge of the Respiratory Drug Delivery Department, which includes the disciplines Drug Product Analytics, Formulation and Process Development, Device and Packaging Development.

Since 2015 he has been responsible for the Quality Unit Chemistry (API) in Operations.